Science Applications Inte... (SAIC)
99.67
-2.96 (-2.88%)
At close: Mar 06, 2025, 1:58 PM
Science Applications International Cash Flow Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 |
| Net Income | 477M | 303M | 279M | 211M | 229M | 137M | 179M | 148M | 117M | 141M | 113M | 524M | -11M | 539M | 465M |
| Depreciation & Amortization | 142M | 157M | 165M | 179M | 138M | 49M | 46M | 53M | 62M | 21M | 13M | 113M | 114M | 110M | 90M |
| Stock-Based Compensation | 68M | 48M | 46M | 42M | 37M | 45M | 27M | 31M | 33M | 35M | 33M | 84M | 84M | 99M | 103M |
| Other Working Capital | 55M | -18M | -34M | -5M | -4M | -11M | 19M | -21M | -8M | 5M | 7M | 72M | -9M | 9M | -19M |
| Other Non-Cash Items | -253M | -1M | -10M | 18M | 5M | 40M | 184M | -15M | -9M | -3M | 57M | 3M | -1M | 1M | 1M |
| Deferred Income Tax | -17M | -17M | 59M | 12M | 44M | 19M | 13M | 1M | 3M | 4M | 18M | 7M | -12M | -1M | -1M |
| Change in Working Capital | -21M | 42M | -21M | 293M | 5M | -106M | -48M | 55M | 20M | 79M | 6M | -386M | 595M | -35M | -48M |
| Operating Cash Flow | 396M | 532M | 518M | 755M | 458M | 184M | 217M | 273M | 226M | 277M | 183M | 345M | 769M | 713M | 610M |
| Capital Expenditures | -27M | -25M | -36M | -46M | -21M | -28M | -22M | -15M | -20M | -22M | -16M | -48M | -65M | -73M | -58M |
| Acquisitions | 348M | n/a | -247M | -1.19B | n/a | -1B | n/a | -2M | -764M | n/a | n/a | -482M | -222M | -382M | -258M |
| Purchase of Investments | -8M | -7M | -9M | -6M | -24M | n/a | n/a | n/a | -14M | n/a | n/a | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | 6M | 4M | 6M | 9M | 3M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | -5M | -8M | -6M | -3M | -5M | 1M | -22M | 6M | -14M | -22M | -16M | 3M | 84M | 10M | 10M |
| Investing Cash Flow | 314M | -36M | -292M | -1.23B | -47M | -1.03B | -22M | -11M | -798M | -22M | -16M | -527M | -203M | -445M | -306M |
| Debt Repayment | -281M | -150M | -3M | 601M | -174M | 1.08B | -25M | -27M | 598M | -13M | 499M | -4M | -2M | 184M | -420M |
| Common Stock Repurchased | -382M | -267M | -226M | -34M | -197M | -69M | -186M | -180M | -69M | -149M | -13M | n/a | n/a | n/a | n/a |
| Dividend Paid | -79M | -83M | -86M | -87M | -87M | -53M | -54M | -54M | -55M | -52M | -322M | -1M | n/a | n/a | n/a |
| Other Financial Acitivies | n/a | -9M | -2M | -29M | -7M | -27M | -2M | 9M | -12M | 3M | -108M | -717M | -300M | n/a | n/a |
| Financial Cash Flow | -725M | -493M | -301M | 464M | -455M | 938M | -261M | -247M | 466M | -208M | 86M | -722M | -446M | 184M | -420M |
| Net Cash Flow | -15M | 3M | -75M | -12M | -44M | 94M | -66M | 15M | -106M | 47M | 253M | -856M | 225M | 506M | -75M |
| Free Cash Flow | 369M | 507M | 482M | 709M | 437M | 156M | 195M | 258M | 206M | 255M | 167M | 297M | 704M | 640M | 552M |